Dong-A ST concludes co-development agreement of immunotherapy with AstraZeneca

Published: 2018-01-15 16:29:00
Updated: 2018-01-15 13:05:41

Dong-A ST(CEO/Vice President Soo-Hyun Kang) announced on the 11th that the company signed a co-development agreement of innovative immunotherapies with AstraZeneca, an English biotech company, at JP Morgan Healthcare Conference in San Francisco, USA, on the 10th, 4pm.

With Dong-A ST Vice Preside...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean




Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.